Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?

Tomljenovic L, Shaw CA.

J Inorg Biochem. 2011 Nov;105(11):1489-99. doi: 10.1016/j.jinorgbio.2011.08.008. Epub 2011 Aug 23.

PMID:
22099159
2.

Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations.

Tomljenovic L, Shaw CA.

Lupus. 2012 Feb;21(2):223-30. doi: 10.1177/0961203311430221.

PMID:
22235057
3.

Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b-CRM197 conjugate vaccine.

Kanra G, Viviani S, Yurdakök K, Ozmert E, Anemona A, Yalçin S, Demiralp O, Bilgili N, Kara A, Cengiz AB, Mutlu B, Baldini A, Marchetti E, Podda A.

Pediatr Int. 2003 Jun;45(3):314-8.

PMID:
12828588
4.

Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators.; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2009 Dec 18;58(10):1-20. Erratum in: MMWR Surveill Summ. 2010 Aug 6;59(30):956.

5.

Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators.; Centers for Disease Control and Prevention..

MMWR Surveill Summ. 2012 Mar 30;61(3):1-19.

6.

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

Shaw CA, Li D, Tomljenovic L.

Immunotherapy. 2014;6(10):1055-71. doi: 10.2217/imt.14.81. Review.

PMID:
25428645
7.

Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010.

Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators.; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2014 Mar 28;63(2):1-21.

8.

Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators.; Centers for Disease Control and Prevention..

MMWR Surveill Summ. 2007 Feb 9;56(1):12-28.

9.

Prevalence of autism spectrum disorders and influence of country of measurement and ethnicity.

Zaroff CM, Uhm SY.

Soc Psychiatry Psychiatr Epidemiol. 2012 Mar;47(3):395-8. doi: 10.1007/s00127-011-0350-3. Epub 2011 Feb 4. Review.

PMID:
21293843
10.

Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes.

Shaw CA, Li Y, Tomljenovic L.

J Inorg Biochem. 2013 Nov;128:237-44. doi: 10.1016/j.jinorgbio.2013.07.022. Epub 2013 Jul 19.

PMID:
23932735
11.

Aluminum vaccine adjuvants: are they safe?

Tomljenovic L, Shaw CA.

Curr Med Chem. 2011;18(17):2630-7.

PMID:
21568886
12.

Prenatal and perinatal analgesic exposure and autism: an ecological link.

Bauer AZ, Kriebel D.

Environ Health. 2013 May 9;12:41. doi: 10.1186/1476-069X-12-41.

13.

Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children.

Glanz JM, Newcomer SR, Daley MF, McClure DL, Baxter RP, Jackson ML, Naleway AL, Lugg MM, DeStefano F.

Vaccine. 2015 Nov 27;33(48):6736-44. doi: 10.1016/j.vaccine.2015.10.076. Epub 2015 Oct 27.

PMID:
26518400
14.

Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.

Shaw CA, Tomljenovic L.

Immunol Res. 2013 Jul;56(2-3):304-16. doi: 10.1007/s12026-013-8403-1. Review.

PMID:
23609067
15.

Evaluation of C-reactive protein as an inflammatory biomarker in rabbits for vaccine nonclinical safety studies.

Destexhe E, Prinsen MK, van Schöll I, Kuper CF, Garçon N, Veenstra S, Segal L.

J Pharmacol Toxicol Methods. 2013 Nov-Dec;68(3):367-73. doi: 10.1016/j.vascn.2013.04.003. Epub 2013 Apr 23.

PMID:
23624216
16.

Autism spectrum disorders in extremely preterm children.

Johnson S, Hollis C, Kochhar P, Hennessy E, Wolke D, Marlow N.

J Pediatr. 2010 Apr;156(4):525-31.e2. doi: 10.1016/j.jpeds.2009.10.041. Epub 2010 Jan 13.

PMID:
20056232
17.

Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators.; Centers for Disease Control and Prevention..

MMWR Surveill Summ. 2007 Feb 9;56(1):1-11.

18.

Distribution of aluminum in hair of Brazilian infants and correlation to aluminum-adjuvanted vaccine exposure.

Bohrer D, Schmidt M, Marques RC, Dórea JG.

Clin Chim Acta. 2014 Jan 20;428:9-13. doi: 10.1016/j.cca.2013.10.020. Epub 2013 Oct 29.

PMID:
24183841
20.

Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years--Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012.

Christensen DL, Baio J, Van Naarden Braun K, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Lee LC, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate MS, Zahorodny W, Yeargin-Allsopp M; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2016 Apr 1;65(3):1-23. doi: 10.15585/mmwr.ss6503a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2016;65(15):404.

PMID:
27031587

Supplemental Content

Support Center